Why tau pathology so prominently impacts entorhinal and transentorhinal cortex in early AD is unknown, but one can speculate that higher levels of AβOs and perhaps other factors intrinsic to these neurons may contribute. This evidence concerns the gene MAPT and Alzheimer disease.